Cancer Researchers on the Rise: Amin Sobh, Ph.D.
Amin Sobh, Ph.D., studies multiple myeloma, the second most common blood cancer.
Posts tagged as
Jonathan Licht
New trajectory for cancer
With NCI designation, the UF Health Cancer Center is speeding toward a Moonshot goal.
Jonathan D. Licht, M.D., receives LLS Excellence in Scientific Service Award
The LLS Excellence in Scientific Service award recognizes his commitment to the blood cancer community.
Amin Sobh, Ph.D., highlighted in AACR article
The article spotlights Amin Sobh's research advancing new therapeutic targets in multiple myeloma, with the help of AACR funding.
Research Snapshot: UF researchers discover novel crosstalk between epigenetic dysregulation and metabolism in multiple myeloma
Researchers identified a novel mechanism in the epigenome that could pave the way to develop new therapies for multiple myeloma.
Research Snapshot: Researchers uncover role of protein in regulating multiple myeloma immune response
UF Health Cancer Center researchers discovered a role of a protein in regulating genes that affect the immune system response to multiple myeloma.
NCI grant supports UF Health Cancer Center epigenetics research
The R50 Research Specialist Award goes to exceptional scientists pursuing research in the context of an existing NCI-funded cancer research program.
Cancer Research Conference for Science Teachers expands impact
Nearly 120 educators from six states across the Southeast attended this year's Cancer Research Conference for Science Teachers.
With NCI designation, UF Health Cancer Center accelerates research impact
On the anniversary of achieving NCI designation, a look at 10 key achievements over the past year.
Jonathan Licht featured on Oncology Overdrive podcast
Jonathan Licht, M.D., spoke with host Shikha Jain, M.D., about leadership, NCI designation and more.
